Global Institute for Novel Nicotine (GINN)

The Global Institute for Novel Nicotine (GINN) is dedicated to shaping the future of novel nicotine products through comprehensive research and collaborative efforts. As a leading industry association, GINN fosters innovation and advocates for the responsible development of reduced-risk alternatives, contributing to a safer future for consumers globally. The institute is committed to promoting science-driven regulations and supporting advancements in the field.

GINN actively promotes collaboration among industry leaders, researchers, and policymakers to address regulatory challenges and ensure the highest standards of product development. The Global Institute for Novel Nicotine supports research and education on harm reduction, positioning itself as a trusted voice in the evolving landscape of tobacco harm reduction and nicotine innovation. Operating from its primary address in London, GINN is at the forefront of shaping the industry's trajectory.

The Global Institute for Novel Nicotine (GINN) continuously strives to foster a collaborative environment that encourages the exchange of ideas and best practices. To learn more about how GINN is driving innovation and progress in the novel nicotine industry, we invite you to explore our ongoing projects and initiatives. Manager, we invite you to create a customized and exclusive company showcase and product listing on our platform.